Kurse um 15 Minuten verzögert
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 17. September 2026 | 273,15 | 273,86 | 267,95 | 269,44 | 2 Mio. |
| 16. September 2026 | 270,89 | 273,56 | 268,57 | 268,82 | 2 Mio. |
| 15. September 2026 | 263,17 | 272,35 | 262,95 | 269,67 | 1 Mio. |
| 14. September 2026 | 265,77 | 267,95 |
Auf Basis der Berichte bis 31. Dezember 2025
IQVIA runs clinical trials for drug companies and sells pharmaceutical market data.
For a drug developer it is cheaper to hire a contractor than to maintain its own network of research sites: a trial requires hundreds of locations across countries, physician coordination and regulatory reporting. The company does this professionally and secures contracts years ahead.
The second part is data: prescription and drug sales information bought by the same pharmaceutical companies for planning. That is subscription revenue at high margins. Risks: reduced research budgets, especially at biotech start-ups dependent on raising capital. The trial backlog is the leading indicator, and it turns months before revenue does. The company pays no dividend.
Adresse:2400 ELLIS ROAD, DURHAM, NC, 27703, US
| 112 Mio. |
| BIAFbioAffinity Technologies, Inc. | 10,10 | +1.543,00 % | 52 Mio. |
| ABSIAbsci Corporation | 9,52 | +269,70 % | 24 Mio. |
| OABIOmniAb, Inc. | 4,37 | −168,90 % | 9 Mio. |
| NRCNRC Health | 20,81 | −28,80 % | 3 Mio. |
| 262,56 |
| 265,67 |
| 1 Mio. |
| 11. September 2026 | 258,82 | 262,89 | 256,97 | 261,77 | 1 Mio. |
| 10. September 2026 | 254,57 | 258,93 | 252,53 | 257,30 | 1 Mio. |
| 09. September 2026 | 257,10 | 258,14 | 254,21 | 256,98 | 1 Mio. |
| 08. September 2026 | 264,00 | 264,79 | 259,00 | 259,21 | 1 Mio. |
| 04. September 2026 | 268,48 | 271,80 | 262,60 | 267,77 | 1 Mio. |
| 03. September 2026 | 265,81 | 271,71 | 263,38 | 271,62 | 2 Mio. |
| 02. September 2026 | 258,00 | 266,08 | 257,18 | 263,84 | 1 Mio. |
| 01. September 2026 | 262,09 | 262,64 | 257,19 | 258,35 | 1 Mio. |
| 31. August 2026 | 258,07 | 261,87 | 256,02 | 261,19 | 1 Mio. |
| 28. August 2026 | 260,55 | 262,82 | 258,08 | 261,75 | 2 Mio. |
| 27. August 2026 | 261,49 | 265,25 | 259,75 | 262,38 | 1 Mio. |
| 26. August 2026 | 254,91 | 262,51 | 253,16 | 261,51 | 1 Mio. |
| 25. August 2026 | 258,59 | 261,80 | 256,45 | 259,42 | 901.400 |
| 24. August 2026 | 256,81 | 261,88 | 255,79 | 260,24 | 1 Mio. |
| 21. August 2026 | 256,79 | 260,40 | 254,93 | 259,82 | 1 Mio. |
| 20. August 2026 | 246,87 | 260,30 | 246,87 | 256,05 | 2 Mio. |